124 related articles for article (PubMed ID: 19808332)
1. Letter by Nguyen and Doenst regarding article "Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart-failure prone rat".
Nguyen TD; Doenst T
Circ Heart Fail; 2009 May; 2(3):e1; author reply e2. PubMed ID: 19808332
[No Abstract] [Full Text] [Related]
2. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
Bartha E; Solti I; Kereskai L; Lantos J; Plozer E; Magyar K; Szabados E; Kálai T; Hideg K; Halmosi R; Sumegi B; Toth K
Cardiovasc Res; 2009 Aug; 83(3):501-10. PubMed ID: 19443425
[TBL] [Abstract][Full Text] [Related]
3. Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart failure-prone rat.
Poornima I; Brown SB; Bhashyam S; Parikh P; Bolukoglu H; Shannon RP
Circ Heart Fail; 2008 Sep; 1(3):153-60. PubMed ID: 19727407
[TBL] [Abstract][Full Text] [Related]
4. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
5. Iptakalim: a new or just another KCO?
Costa AD
Cardiovasc Res; 2009 Aug; 83(3):417-8. PubMed ID: 19515796
[No Abstract] [Full Text] [Related]
6. Cardiovascular changes during maturation and ageing in male and female spontaneously hypertensive rats.
Chan V; Fenning A; Levick SP; Loch D; Chunduri P; Iyer A; Teo YL; Hoey A; Wilson K; Burstow D; Brown L
J Cardiovasc Pharmacol; 2011 Apr; 57(4):469-78. PubMed ID: 21283019
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide 1--a cardiologic dimension.
Treiman M; Elvekjaer M; Engstrøm T; Jensen JS
Trends Cardiovasc Med; 2010 Jan; 20(1):8-12. PubMed ID: 20685571
[TBL] [Abstract][Full Text] [Related]
8. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
9. Cardiac metabolism as a target for the treatment of heart failure.
Taegtmeyer H
Circulation; 2004 Aug; 110(8):894-6. PubMed ID: 15326079
[No Abstract] [Full Text] [Related]
10. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
Henderson KK; Danzi S; Paul JT; Leya G; Klein I; Samarel AM
Circ Heart Fail; 2009 May; 2(3):243-52. PubMed ID: 19808346
[TBL] [Abstract][Full Text] [Related]
11. Adenosine A1 receptor antagonists at a fork in the road.
Givertz MM
Circ Heart Fail; 2009 Nov; 2(6):519-22. PubMed ID: 19919975
[No Abstract] [Full Text] [Related]
12. Systolic time intervals as indicators for cardiac function in rat models for heart failure.
Schoemaker RG; Smits JF
Eur Heart J; 1990 Dec; 11 Suppl I():114-23. PubMed ID: 2092980
[TBL] [Abstract][Full Text] [Related]
13. Targeting survival signaling in heart failure.
Morissette MR; Rosenzweig A
Curr Opin Pharmacol; 2005 Apr; 5(2):165-70. PubMed ID: 15780826
[TBL] [Abstract][Full Text] [Related]
14. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin in cardioprotection: does it have a future or is it all in the past?
Mehta JL
Cardiovasc Res; 2008 Sep; 79(4):549-50. PubMed ID: 18583337
[No Abstract] [Full Text] [Related]
16. Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure.
Burstein B; Comtois P; Michael G; Nishida K; Villeneuve L; Yeh YH; Nattel S
Circ Res; 2009 Dec; 105(12):1213-22. PubMed ID: 19875729
[TBL] [Abstract][Full Text] [Related]
17. [Alterations in left ventricular systolic and diastolic function in conscious dogs with pacing-induced heart failure].
Komamura K; Vatner SF
Jpn Circ J; 1993; 57 Suppl 4():1238-40. PubMed ID: 7966954
[No Abstract] [Full Text] [Related]
18. Towards the second generation of skeletal myoblasts?
Menasché P
Cardiovasc Res; 2008 Aug; 79(3):355-6. PubMed ID: 18508855
[No Abstract] [Full Text] [Related]
19. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model.
Zhang Y; Popovic ZB; Bibevski S; Fakhry I; Sica DA; Van Wagoner DR; Mazgalev TN
Circ Heart Fail; 2009 Nov; 2(6):692-9. PubMed ID: 19919995
[TBL] [Abstract][Full Text] [Related]
20. Drugs for treatment of chronic heart failure.
Treat Guidel Med Lett; 2009 Jul; 7(83):53-6. PubMed ID: 19556942
[No Abstract] [Full Text] [Related]
[Next] [New Search]
